Seagen to highlight research from 16 presentations across multiple tumor types at esmo 2021

Bothell, wash.--(business wire)--seagen inc. (nasdaq: sgen) today announced data and trials in progress from its diverse and growing portfolio of marketed and investigational therapies will be presented at the virtual european society for medical oncology (esmo) 2021 annual meeting, to be held from september 16-21. sixteen presentations will demonstrate the breadth of seagen's portfolio and development activities, across multiple cancer types - including a mini oral presentation featuring resul
SGEN Ratings Summary
SGEN Quant Ranking